Shilpa Sambashivan

Shilpa Sambashivan has over 10 years of experience in the biopharmaceutical industry. Shilpa is currently serving as the Chief Scientific Officer at Nura Bio since April 2018. Prior to that, they worked at Amgen Inc. for 7 years as a Project Team Lead. Before joining Amgen Inc., Shilpa worked as a Scientist at NGM Biopharmaceuticals Inc. from 2009 to 2011.

Shilpa Sambashivan's education history includes a Master of Science (Hons) degree in Biological Sciences from Birla Institute of Technology and Science, Pilani. Shilpa further pursued a Ph.D. in Molecular Biology and Protein Biochemistry at UCLA. Following this, they engaged in postdoctoral research at UCLA before obtaining a Genentech Foundation Bio-X Postdoctoral Fellowship at Stanford University. The specific start and end years for each of these educational experiences are not provided.